Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.98 EUR | +0.71% | -6.89% | -19.77% |
09-13 | RTW Biotech half-year net asset value rises amid "challenging markets" | AN |
09-12 | German Shares Advance as ECB Delivers Widely Expected Rate Cut | MT |
Analyst Opinion | 4m Target Price Revision | 4m Revision of opinion | Divergence of analysts' opinions | Divergence of Target Price | Average Target P. | Ecart obj. / dr | Nbr of analysts | ||
---|---|---|---|---|---|---|---|---|---|
35.59 | +32.85% | 22 | |||||||
986.82 | +5.54% | 25 | |||||||
967.54 | +5.83% | 26 | |||||||
170.67 | +3.66% | 22 | |||||||
196.30 | +1.18% | 27 | |||||||
139.03 | +20.63% | 26 | |||||||
296.42 | +12.71% | 19 | |||||||
183.99 | +16.78% | 20 | |||||||
116.54 | +1.06% | 20 | |||||||
324.71 | -1.62% | 24 | |||||||
33.23 | +13.97% | 22 | |||||||
112.17 | +9.12% | 22 | |||||||
83.54 | +0.46% | 27 | |||||||
53.34 | +10.57% | 21 | |||||||
19.68 | +20.11% | 21 | |||||||
6,663.33 | -2.47% | 15 | |||||||
6,531.25 | +28.29% | 16 | |||||||
4,768.83 | +12.77% | 18 | |||||||
3.842 | -0.83% | 17 | |||||||
Average | 1,141.41 | +10.03% | 22 | ||||||
Weighted average by Cap. | 712.66 | +7.77% | 23 |
- Stock Market
- Equities
- BAYN Stock
- Sector Bayer AG
- Sector consensus
MarketScreener is also available in this country: United States.
Switch edition